Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$2.49 - $3.5 $139,086 - $195,503
55,858 New
55,858 $141,000
Q1 2022

May 16, 2022

SELL
$3.0 - $4.25 $1.02 Million - $1.44 Million
-339,890 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$3.85 - $6.71 $1.31 Million - $2.28 Million
339,890 New
339,890 $1.33 Million
Q3 2020

Nov 16, 2020

SELL
$4.96 - $7.08 $653,668 - $933,059
-131,788 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$4.84 - $8.02 $635,269 - $1.05 Million
131,254 Added 24579.4%
131,788 $792,000
Q1 2020

May 15, 2020

BUY
$4.52 - $8.55 $2,413 - $4,565
534 New
534 $3,000

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $820M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.